Stocks / Stock overview

Cme Group Inc. (CME)

$274.98+1.52%Aft $275.14 (+0.06%)Market cap $98.88B

NasdaqGS · Price as of · Nasdaq Real Time Price

Stock Scorer
Scoring…
Analyst consensus
Hold$283.07
  • Analysts15
  • Implied upside+2.9%
  • Target range$230.00 to $330.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
October 21, 2026before the open
  • EPS expected$2.94 +9.7%
  • A year ago$2.68
  • Revenue expected$1.70B +10%
  • Estimate range$2.81 to $3.15
Consensus of 13 analysts for the quarter ending September 30, 2026. Beat the estimate in 3 of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar

Congress trades

Source: STOCK Act disclosures filed with the House and SenateLatest disclosed

DateMemberActionAmount
2026-06-16Gil Cisneros CASale$1,001 - $15,000
All congress trades

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
8-KAugust 11, 20268-K
10-QJuly 24, 202610-Q
8-KJuly 22, 20268-K
4June 29, 2026FORM 4
4June 29, 2026FORM 4
4June 29, 2026FORM 4
4June 29, 2026FORM 4
4June 29, 2026FORM 4
All SEC filings

Frequently asked questions

When does CME report earnings?

Cme Group Inc. (CME) is scheduled to report quarterly results on October 21, 2026, before the open. The 13-analyst consensus is $2.94 per share on revenue of $1.70B for the quarter ending September 30, 2026, against $2.68 and $1.54B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters.

What do analysts expect for CME?

15 analysts cover Cme Group Inc. (CME). The consensus rating is Hold. The average price target is $283.07, in a range of $230.00 to $330.00.

Are insiders buying or selling CME?

We have no qualifying Form 4 insider purchases or sales on record for Cme Group Inc. (CME). Sales are only tracked above a dollar threshold, so small routine trades may not appear.

Where can I see CME SEC filings?

Recent filings are listed on this page, newest first. The latest is an 8-K filed August 11, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.